TScan Therapeutics Inc banner

Wall St Price Targets

TCRX Price Forecast
Based on 4 analysts

+575% Upside
from $0.151 today

TScan Therapeutics Inc (TCRX)’s 12-month stock price forecast through November 2027 has a consensus target of $1.02, implying 575% upside. The forecast is based on price targets from 4 Wall Street analysts.

TCRX Analyst Rating
Based on 5 analysts

avg. 3.4 of 5
Strong buy
1 20%
Buy
0 0%
Hold
4 80%
Sell
0 0%
Strong sell
0 0%

Analysts rate TCRX Hold, with 4 of 5 recommending Hold.

TScan Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TCRX's stock price target?
Price Target
1.02 USD

According to Wall Street analysts, the average 1-year price target for TCRX is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

What is the Revenue forecast for TScan Therapeutics Inc?
Projected CAGR
61%

Over the last 5 years, the compound annual growth rate for Revenue has been 57%. The projected CAGR for the next 8 years is 61%.

Back to Top